Cargando…

Oral glucose tolerance test predicts increased carotid plaque burden in patients with acute coronary syndrome

BACKGROUND: Type 2 diabetes and prediabetes are established risk factors for atherosclerosis. The aim of this study was to evaluate the atherosclerotic plaque burden in the carotid arteries of patients with acute coronary syndrome according to their glycemic status. METHODS: Patients with acute coro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bjarnason, Thorarinn A., Hafthorsson, Steinar O., Kristinsdottir, Linda B., Oskarsdottir, Erna S., Aspelund, Thor, Sigurdsson, Sigurdur, Gudnason, Vilmundur, Andersen, Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576679/
https://www.ncbi.nlm.nih.gov/pubmed/28854264
http://dx.doi.org/10.1371/journal.pone.0183839
_version_ 1783260230891601920
author Bjarnason, Thorarinn A.
Hafthorsson, Steinar O.
Kristinsdottir, Linda B.
Oskarsdottir, Erna S.
Aspelund, Thor
Sigurdsson, Sigurdur
Gudnason, Vilmundur
Andersen, Karl
author_facet Bjarnason, Thorarinn A.
Hafthorsson, Steinar O.
Kristinsdottir, Linda B.
Oskarsdottir, Erna S.
Aspelund, Thor
Sigurdsson, Sigurdur
Gudnason, Vilmundur
Andersen, Karl
author_sort Bjarnason, Thorarinn A.
collection PubMed
description BACKGROUND: Type 2 diabetes and prediabetes are established risk factors for atherosclerosis. The aim of this study was to evaluate the atherosclerotic plaque burden in the carotid arteries of patients with acute coronary syndrome according to their glycemic status. METHODS: Patients with acute coronary syndrome and no previous history of type 2 diabetes were consecutively included in the study. Glucose metabolism was evaluated with fasting glucose in plasma, HbA1c and a standard two-hour oral glucose tolerance test. Atherosclerotic plaque in the carotid arteries was evaluated with a standardized ultrasound examination where total plaque area was measured and patients classified as having no plaque or a significant plaque formation. RESULTS: A total of 245 acute coronary syndrome patients (male 78%, 64 years (SD: 10.9)) were included. The proportion diagnosed with normal glucose metabolism, prediabetes and type 2 diabetes was 28.6%, 64.1% and 7.3%, respectively. A significant atherosclerotic plaque was found in 48.5%, 66.9% and 72.2% of patients with normal glucose metabolism, prediabetes and type 2 diabetes, respectively. An incremental increase in total plaque area was found from normal glucose metabolism to prediabetes (25.5%) and from normal glucose metabolism to type 2 diabetes (35.9%) (p = 0.04). When adjusted for conventional cardiovascular risk factors the OR of having significant atherosclerotic plaque in the carotid arteries was 2.17 (95% CI 1.15–4.15) for patients with newly diagnosed dysglycemia compared to patients with normal glucose metabolism. When additionally adjusted for the 2-hour plasma glucose after glucose loading (2hPG) the OR attenuated to 1.77 (95% CI 0.83–3.84). CONCLUSION: Newly detected dysglycemia is an independent predictor of significant atherosclerotic plaque in the carotid arteries with oral glucose tolerance test as a major determinant of carotid plaque burden in this group of individuals with acute coronary syndrome.
format Online
Article
Text
id pubmed-5576679
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55766792017-09-15 Oral glucose tolerance test predicts increased carotid plaque burden in patients with acute coronary syndrome Bjarnason, Thorarinn A. Hafthorsson, Steinar O. Kristinsdottir, Linda B. Oskarsdottir, Erna S. Aspelund, Thor Sigurdsson, Sigurdur Gudnason, Vilmundur Andersen, Karl PLoS One Research Article BACKGROUND: Type 2 diabetes and prediabetes are established risk factors for atherosclerosis. The aim of this study was to evaluate the atherosclerotic plaque burden in the carotid arteries of patients with acute coronary syndrome according to their glycemic status. METHODS: Patients with acute coronary syndrome and no previous history of type 2 diabetes were consecutively included in the study. Glucose metabolism was evaluated with fasting glucose in plasma, HbA1c and a standard two-hour oral glucose tolerance test. Atherosclerotic plaque in the carotid arteries was evaluated with a standardized ultrasound examination where total plaque area was measured and patients classified as having no plaque or a significant plaque formation. RESULTS: A total of 245 acute coronary syndrome patients (male 78%, 64 years (SD: 10.9)) were included. The proportion diagnosed with normal glucose metabolism, prediabetes and type 2 diabetes was 28.6%, 64.1% and 7.3%, respectively. A significant atherosclerotic plaque was found in 48.5%, 66.9% and 72.2% of patients with normal glucose metabolism, prediabetes and type 2 diabetes, respectively. An incremental increase in total plaque area was found from normal glucose metabolism to prediabetes (25.5%) and from normal glucose metabolism to type 2 diabetes (35.9%) (p = 0.04). When adjusted for conventional cardiovascular risk factors the OR of having significant atherosclerotic plaque in the carotid arteries was 2.17 (95% CI 1.15–4.15) for patients with newly diagnosed dysglycemia compared to patients with normal glucose metabolism. When additionally adjusted for the 2-hour plasma glucose after glucose loading (2hPG) the OR attenuated to 1.77 (95% CI 0.83–3.84). CONCLUSION: Newly detected dysglycemia is an independent predictor of significant atherosclerotic plaque in the carotid arteries with oral glucose tolerance test as a major determinant of carotid plaque burden in this group of individuals with acute coronary syndrome. Public Library of Science 2017-08-30 /pmc/articles/PMC5576679/ /pubmed/28854264 http://dx.doi.org/10.1371/journal.pone.0183839 Text en © 2017 Bjarnason et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Bjarnason, Thorarinn A.
Hafthorsson, Steinar O.
Kristinsdottir, Linda B.
Oskarsdottir, Erna S.
Aspelund, Thor
Sigurdsson, Sigurdur
Gudnason, Vilmundur
Andersen, Karl
Oral glucose tolerance test predicts increased carotid plaque burden in patients with acute coronary syndrome
title Oral glucose tolerance test predicts increased carotid plaque burden in patients with acute coronary syndrome
title_full Oral glucose tolerance test predicts increased carotid plaque burden in patients with acute coronary syndrome
title_fullStr Oral glucose tolerance test predicts increased carotid plaque burden in patients with acute coronary syndrome
title_full_unstemmed Oral glucose tolerance test predicts increased carotid plaque burden in patients with acute coronary syndrome
title_short Oral glucose tolerance test predicts increased carotid plaque burden in patients with acute coronary syndrome
title_sort oral glucose tolerance test predicts increased carotid plaque burden in patients with acute coronary syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576679/
https://www.ncbi.nlm.nih.gov/pubmed/28854264
http://dx.doi.org/10.1371/journal.pone.0183839
work_keys_str_mv AT bjarnasonthorarinna oralglucosetolerancetestpredictsincreasedcarotidplaqueburdeninpatientswithacutecoronarysyndrome
AT hafthorssonsteinaro oralglucosetolerancetestpredictsincreasedcarotidplaqueburdeninpatientswithacutecoronarysyndrome
AT kristinsdottirlindab oralglucosetolerancetestpredictsincreasedcarotidplaqueburdeninpatientswithacutecoronarysyndrome
AT oskarsdottirernas oralglucosetolerancetestpredictsincreasedcarotidplaqueburdeninpatientswithacutecoronarysyndrome
AT aspelundthor oralglucosetolerancetestpredictsincreasedcarotidplaqueburdeninpatientswithacutecoronarysyndrome
AT sigurdssonsigurdur oralglucosetolerancetestpredictsincreasedcarotidplaqueburdeninpatientswithacutecoronarysyndrome
AT gudnasonvilmundur oralglucosetolerancetestpredictsincreasedcarotidplaqueburdeninpatientswithacutecoronarysyndrome
AT andersenkarl oralglucosetolerancetestpredictsincreasedcarotidplaqueburdeninpatientswithacutecoronarysyndrome